Drugs / Survivin peptide vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00108875 | Apr 2003 → ? | cervical carcinoma, colon carcinoma, malignant pancreatic neoplasm, melanoma | Julius-Maximilians University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Survivin peptide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00108875 ↗ |
| Modality | Peptide | “peptide vaccine” NCT00108875 ↗ |
| Route | Subcutaneous | “deep subcutaneous injection” NCT00108875 ↗ |